HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hui Tian Selected Research

Type 2 Diabetes Mellitus (MODY)

11/2022[Correlation between glycemic variability and glycosylated hemoglobin level during follow-up in elderly male patients with type 2 diabetes in Beijing].
1/2022Reversal of Diabesity: Normalization of Insulin Release Curve in Association with Reversal of Non-Alcoholic Fatty Liver Disease.
3/2021One-hour plasma glucose concentration can identify elderly Chinese male subjects at high risk for future type 2 diabetes mellitus: A 20-year retrospective and prospective study.
6/2020DPP-4 inhibition resembles exercise in preventing type 2 diabetes development by inhibiting hepatic protein kinase Cε expression in a mouse model of hyperinsulinemia.
11/2019Glycemic control and comprehensive metabolic risk factors control in older adults with type 2 diabetes.
1/2019FGF19 Analog as a Surgical Factor Mimetic That Contributes to Metabolic Effects Beyond Glucose Homeostasis.
1/2016Assessment of Insulin Resistance in Subjects with Normal Glucose Tolerance, Hyperinsulinemia with Normal Blood Glucose Tolerance, Impaired Glucose Tolerance, and Newly Diagnosed Type 2 Diabetes (Prediabetes Insulin Resistance Research).
11/2014Lixisenatide treatment improves glycaemic control in Asian patients with type 2 diabetes mellitus inadequately controlled on metformin with or without sulfonylurea: a randomized, double-blind, placebo-controlled, 24-week trial (GetGoal-M-Asia).
8/2014Association between glycemic indices and beta cell function in patients with newly diagnosed type 2 diabetes.
6/2014Comparison of repaglinide and metformin monotherapy as an initial therapy in Chinese patients with newly diagnosed type 2 diabetes mellitus.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hui Tian Research Topics

Disease

123Neoplasms (Cancer)
02/2024 - 03/2002
32Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2024 - 05/2007
22Lung Neoplasms (Lung Cancer)
04/2023 - 08/2004
22Type 2 Diabetes Mellitus (MODY)
11/2022 - 06/2002
20Neoplasm Metastasis (Metastasis)
09/2022 - 12/2007
14Infections
01/2023 - 05/2017
13Carcinogenesis
12/2023 - 08/2004
12Adenocarcinoma of Lung
01/2024 - 12/2018
9Esophageal Squamous Cell Carcinoma
01/2024 - 01/2014
9Body Weight (Weight, Body)
05/2023 - 02/2012
9Melanoma (Melanoma, Malignant)
01/2023 - 12/2012
8Inflammation (Inflammations)
09/2023 - 06/2006
8Lymphatic Metastasis
01/2021 - 11/2010
8Insulin Resistance
12/2017 - 06/2002
6Hyperglycemia
03/2023 - 03/2004
6Hyperinsulinism (Hyperinsulinemia)
06/2020 - 06/2010
6Metabolic Syndrome (Dysmetabolic Syndrome X)
12/2017 - 09/2008
6Glucose Intolerance
01/2016 - 03/2004
6Brain Ischemia (Cerebral Ischemia)
08/2014 - 01/2003
6Ischemia
11/2006 - 01/2003
5Carcinoma (Carcinomatosis)
01/2024 - 03/2003
5Colorectal Neoplasms (Colorectal Cancer)
10/2023 - 10/2014
5Renal Cell Carcinoma (Grawitz Tumor)
10/2023 - 02/2021
5Sepsis (Septicemia)
07/2023 - 07/2018
5Esophageal Neoplasms (Esophageal Cancer)
01/2023 - 11/2008
5Pain (Aches)
10/2022 - 06/2006
5Hepatocellular Carcinoma (Hepatoma)
09/2022 - 06/2014
5Breast Neoplasms (Breast Cancer)
01/2021 - 03/2008
4Chronic Obstructive Pulmonary Disease (COPD)
10/2023 - 12/2009
4Hypertension (High Blood Pressure)
03/2023 - 07/2010
4Hemorrhage
01/2023 - 03/2022
4Hypoxia (Hypoxemia)
01/2022 - 01/2014
4Non-alcoholic Fatty Liver Disease
01/2022 - 12/2017
4Fibrosis (Cirrhosis)
10/2021 - 01/2011
4Hypoglycemia (Reactive Hypoglycemia)
01/2018 - 07/2004
3Mycoses (Diseases, Fungus)
08/2022 - 01/2019
3Colonic Neoplasms (Colon Cancer)
01/2022 - 05/2007
3Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal)
01/2022 - 01/2018
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2021 - 01/2017
3Starvation
02/2020 - 08/2013
3Infertility (Sterility)
01/2020 - 02/2009

Drug/Important Bio-Agent (IBA)

41Proteins (Proteins, Gene)FDA Link
01/2024 - 09/2003
27Glucose (Dextrose)FDA LinkGeneric
03/2023 - 03/2004
15Biomarkers (Surrogate Marker)IBA
12/2023 - 12/2009
14MicroRNAs (MicroRNA)IBA
10/2023 - 02/2009
9Insulin (Novolin)FDA Link
01/2022 - 04/2011
8CytokinesIBA
10/2023 - 03/2014
8Phosphotransferases (Kinase)IBA
01/2023 - 01/2003
7EnzymesIBA
10/2023 - 06/2006
7Reactive Oxygen Species (Oxygen Radicals)IBA
05/2023 - 06/2003
7Messenger RNA (mRNA)IBA
01/2023 - 09/2006
7Transcription Factors (Transcription Factor)IBA
10/2022 - 11/2013
7AntioxidantsIBA
07/2016 - 06/2003
6Circular RNAIBA
01/2024 - 01/2019
6Long Noncoding RNAIBA
10/2023 - 11/2018
6VaccinesIBA
10/2023 - 06/2017
670-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 70 kDa)IBA
01/2023 - 01/2016
6Cisplatin (Platino)FDA LinkGeneric
01/2023 - 05/2007
6Therapeutic UsesIBA
09/2022 - 12/2007
6PolyaminesIBA
11/2008 - 06/2006
6Ornithine Decarboxylase (Decarboxylase, Ornithine)IBA
11/2008 - 06/2006
5Indicators and Reagents (Reagents)IBA
10/2023 - 06/2007
5LipopolysaccharidesIBA
10/2023 - 03/2007
5Interleukin-6 (Interleukin 6)IBA
09/2023 - 03/2014
5RNA (Ribonucleic Acid)IBA
07/2023 - 01/2017
5Acetylcysteine (Siran)FDA LinkGeneric
05/2023 - 01/2003
5ErbB Receptors (EGF Receptor)IBA
01/2023 - 10/2015
5LigandsIBA
01/2022 - 03/2014
5CateninsIBA
10/2021 - 02/2014
5Bile Acids and Salts (Bile Acids)IBA
12/2017 - 06/2014
4AntigensIBA
01/2024 - 03/2018
4Oxaliplatin (Eloxatin)FDA LinkGeneric
10/2023 - 01/2019
4Paclitaxel (Taxol)FDA LinkGeneric
10/2023 - 02/2021
4Cadherins (E-Cadherin)IBA
01/2023 - 03/2015
4Metformin (Glucophage)FDA LinkGeneric
01/2021 - 11/2008
4CaspasesIBA
01/2020 - 01/2012
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2016 - 04/2005
3Anti-Bacterial Agents (Antibiotics)IBA
01/2024 - 09/2020
3Carrier Proteins (Binding Protein)IBA
07/2023 - 01/2020
3Chimeric Antigen ReceptorsIBA
07/2023 - 01/2020
3Tyrosine Kinase InhibitorsIBA
01/2023 - 10/2015
3AlbuminsIBA
10/2022 - 03/2004
3GTP-Binding Proteins (G-Protein)IBA
07/2022 - 01/2016
3BilirubinIBA
03/2022 - 01/2010
3AcidsIBA
11/2021 - 06/2003
3M2698IBA
10/2021 - 01/2016
3Protein Kinases (Protein Kinase)IBA
06/2020 - 01/2003
3Vascular Endothelial Growth Factor CIBA
01/2020 - 08/2004
3Antineoplastic Agents (Antineoplastics)IBA
01/2020 - 10/2015
3Apoptosis Regulatory ProteinsIBA
01/2019 - 01/2012

Therapy/Procedure

37Therapeutics
03/2024 - 03/2002
13Immunotherapy
01/2024 - 05/2014
11Drug Therapy (Chemotherapy)
01/2024 - 01/2013
5Length of Stay
10/2022 - 06/2016
5Lymph Node Excision (Lymph Node Dissection)
01/2022 - 10/2017
4Esophagectomy
01/2023 - 05/2015
4Transplantation
01/2021 - 11/2010
3Aftercare (After-Treatment)
05/2023 - 01/2020
3Neoadjuvant Therapy
01/2023 - 07/2022
3Glycemic Control
01/2020 - 01/2014